tiprankstipranks
Advertisement
Advertisement

Ajooni Biotech Submits Un-Audited Financial Results in Compliance with NSE Directive

Story Highlights
Ajooni Biotech Submits Un-Audited Financial Results in Compliance with NSE Directive

Meet Samuel – Your Personal Investing Prophet

An update from Ajooni Biotech Limited ( (IN:AJOONI) ) is now available.

Ajooni Biotech Limited has submitted its un-audited financial results for the quarter and half-year ending September 30, 2025, in a machine-readable format to the National Stock Exchange of India. This submission aligns with NSE’s directive for all listed companies to provide corporate announcements in a searchable form, reflecting Ajooni Biotech’s compliance with regulatory requirements and its commitment to transparency.

More about Ajooni Biotech Limited

Ajooni Biotech Limited operates in the biotechnology industry, focusing on the development and distribution of biotech products. The company is headquartered in Mohali, Punjab, India, and is listed on the National Stock Exchange of India.

Average Trading Volume: 452,379

Technical Sentiment Signal: Sell

Learn more about AJOONI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1